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ABSTRACT
Introduction. Functional and aesthetic outcome after
breast-conserving surgery are vital endpoints for patients
with primary breast cancer. A large variety of oncoplastic
techniques exist; however, it remains unclear which tech-
niques yield the highest rates of local control at first
surgery, omission of reexcision or subsequent mastectomy,
and merits the highest degree of patient satisfaction.
Methods. In this retrospective case cohort trial with a
customized investigational questionnaire for assessment of
patient satisfaction with the surgical result, we analyzed
1,035 patients with primary, unilateral breast cancer and
oncoplastic surgery from 2004 to 2009.
Results. Analysis of patient reported outcome (PRO) re-
vealed that 88 % of the cohort was satisfied with their
aesthetic result using oncoplastic techniques following the
concept presented. These results also were achieved in
difficult tumor localizations, such as upper inner and lower
inner quadrant. Conversion rate from breast-conserving
therapy to secondary mastectomy was low at 7.2 %
(n = 68/944 patients). The systematization of oncoplastic
techniques presented—embedded in a multimodal concept
of breast cancer therapy—facilitates tumor control with a
few number of uncomplicated techniques adapted to tumor
site and size with a median resection of 32 (range 11–793)
g. Five-year recurrence rate in our cohort was 4.0 %.
Conclusions. Patient´s satisfaction was independent from
age, body mass index, resection volume, tumor localiza-
tion, and type of oncoplastic surgery (p[ 0.05). We
identified postoperative pain as an important negative im-
pact factor on patient´s satisfaction with the aesthetic result
(p = 0.0001).
The oncologic outcome of breast-conserving surgery is
equivalent to mastectomy, when free margins are achieved
and adjuvant radiotherapy of the operated breast is ap-
plied.1–5 Oncoplastic breast conserving techniques combine
two aspects: oncological safety with a resection of the tumor
with free margins and optimal aesthetic aspects.6–8 Breast-
conserving oncoplastic techniques divide into volume dis-
placement and volume replacement techniques: the first are
constituted by rotational mammaplasty techniques (glandu-
lar rotation mammaplasty, dermoglandular rotation
mammaplasty and tumor-adapted mastopexy), the latter by
latissimus-dorsi-flap and lateral thoracic advancement
flap.9–11 We investigated the options and limitations of on-
coplastic surgery as well as patient satisfaction in a large
cohort of oncoplastic patients. As primary endpoints, we
defined: the oncological safety of oncoplastic breast surgery
(clear margins, low recurrence rate) and feasibility (reexci-
sion rates, secondary mastectomy rates) as well as patient
satisfaction [patient-reported outcome (PRO)].
PATIENTS AND METHODS
We analysed data of 1,035 oncoplastic patients in a
breast unit of maximum care from 2004 to 2009 retrieved
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from patient charts and used a customized questionnaire for
evaluation of current patient satisfaction. An additional
questionnaire as a validated instrument of perceived es-
thetic and functional status of the breast was used, i.e.,
‘‘BCTOS’’ (Breast Cancer Treatment Outcome Scale), first
described by Stanton et al.,12 and ratings in this scale were
correlated to the ratings in our customized questionnaire.
Data cutoff was at February 2013. We explored the
following characteristics, comorbidities, and surgery-re-
lated complications:
– Patient characteristics (body-mass-index, age, menar-
che, menopause, family history of breast cancer)
– Tumor characteristics (histology, TNM-classification,
immunohistochemical subtype, tumor localization)
– Surgical treatment characteristics (local therapy: op-
eration—type of surgery, margins, reexcision rate,
resection volume)
– Physical sequelae/complications: (early: \14 days;
late: C14 days)
– Pain scale
– Secondary mastectomy rates and its influencing factors
– Patient satisfaction with the aesthetic outcome
– Disease-free and overall survival
Intrinsic subtypes have been approximated by im-
munohistochemical characterization according to 12th St.
Gallen International Consensus Conference.13 This study
complies with the principles of the Declaration of Helsinki
and was approved by the institutional review board.
Surgical Techniques
Surgical techniques were based first on tumour location,
second on the condition whether the lesion was unicentric
or multicentric, and whether resection volume would ex-
ceed [20 % of the breast. For all locations of the upper
hemisphere of the breast and unicentric tumours, glandular
rotation mammaplasty was the standard option for re-
shaping of the breast. With multicentricity or breast
resection[20 % or tumours of the lower hemisphere of the
breast, a reduction mammaplasty pattern was applied (in-
ferior-pedicled technique described by Ribeiro in the
modification of the author) to reconstitute the optimal
breast form. This procedure avoids birds peak deformations
for patients with gross resection of tissue in the lower
quadrants of the breast. Where fat tissue was readily ac-
cessible for volume displacement without necessity of
musculocutaneous flaps, this was incorporated in the con-
cept of reshaping of the breast such as the thoracoepigastric
flap for the lower quadrants (in cases of skin resection) and
lateral thoracic advancement flap for the upper outer
quadrant (in cases with need of additional volume
replacement).9
Statistics
Because statistical tests—v2/Likelihood, Mantel–Haen-
szel test, and Wilcoxon’s test—for calculation were
applied, p values must be seen as descriptive, not adjusted.
Log-rank test and Wilcoxon rank-sum tests were used
(Fig. 1). To calculate 5-year overall survival and disease-
free survival, the date of death or local recurrence was
defined as the endpoint, respectively, and the duration of
follow-up was calculated as the date of breast-conserving
surgery to this endpoint.
RESULTS
Of 1,035 patients with oncoplastic operations, 944 pa-
tients met the inclusion criteria (REMARK diagram, see
Supplement, Material 1); 70.7 % (624/882) of patients re-
sponded to the emission of questionnaires. Average age
was 57.6 years (median 58, range 25–88 years). Patient
characteristics are shown in Table 1.
The selection of an oncoplastic technique presented
follows a nomogram that we adapted to the tumor local-
ization, tumor size, and the volume of the breast. The
different choices of techniques are displayed in Fig. 2.
In the lower hemisphere of the breast, 55.4 % of tumors
were operated by tumor-adapted mastopexy, whereas
glandular rotation mammoplasty was less frequently used
here (36.2 %). In the upper part of the breast, glandular
rotation mammoplasty was the most frequently used tech-
nique (69.5 %), whereas tumor-adapted mastopexy was not
commonly performed (11.3 %, p[ 0.001). One-third
(29.7 %) of multicentric or multifocal tumors were oper-
ated by tumor-adapted mastopexy. Dermoglandular
rotation mammaplasty and lateral thoracic advancement
flap are predominantly performed in cases of involvement
of the upper outer quadrant of the breast. Glandular rota-
tion mammaplasty and latissimus-dorsi-flap were not
associated with specific tumor locations (Table 2). The
tumor-adapted mastopexy was characterized by a sig-
nificantly higher median resection volume (52 g) compared
with the glandular rotation mammaplasty (29 g;
p\ 0.001). Tumor size was not a determining factor for
the choice of a certain oncoplastic technique (p[ 0.05).
Aesthetic Outcome
From 624 responders, 558 patients provided information
about patient satisfaction with the aesthetic outcome
(PRO). Results of PRO revealed a total of high degree of
satisfaction with 78 % rating the aesthetic result as very
good (55 %) or good (23 %). Combined with the rating
‘‘satisfactory’’ (10 %), a total of 88 % were satisfied with
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their surgical result. Five percent scored ‘‘fair,’’ 3 % ‘‘in-
sufficient,’’ and 5 % ‘‘unsatisfactory.’’
Aesthetic Outcome in Questionnaires and Breast
Cancer Treatment Outcome Scale
We compared the ratings of aesthetic outcome in our
customized questionnaires with the results of the Breast
Cancer Treatment Outcome Scale (BCTOS).12 In the
BCTOS ratings, patients evaluated the outcome of the
treated vs. untreated breast in 80.3 and 83.5 %, respectively,
as ‘‘no difference or almost no difference’’ regarding the size
and form of the breast. We found a significant correlation for
good functional and aesthetic outcome in the BCTOS (= no
difference or almost no difference) with high ratings of sat-
isfaction in our customized questionnaire (p\ 0.001).
Factors that Influence the Perception of the Aesthetic
Result
Factors that negatively influence the assessment of the
aesthetic result were postoperative pain, wound infection,
and issues related to scars. A higher intensity of pain on a
visual analogue scale (VAS) C5 also was associated with
less satisfaction with aesthetic outcome (p\ 0.0001). Vice
versa, those patients rating the aesthetic result as ‘‘very
good’’ and ‘‘good’’ experienced low pain intensity in
86.3 % during the period of 14 days after surgery. This
trend corresponded well with the perception of patients
beyond the first 2 weeks after surgery.
Complication rate was low with 3.3 % wound infection
(20/624), 9.5 % broadening of the scars (56/624), and
7.9 % occurrence of keloids (47/624). A total of 60.1 % of
patients experienced perceptibility of the scar by palpation
(346/624). The correlation of these complications with a
lower rating of the aesthetic result was statistically sig-
nificant [wound infection (p\ 0.0001), broadening of the
scars (p\ 0.0001), perceptibility of the scars by palpation
(p\ 0.0001), and occurrence of keloids (p\ 0.0001)].
Factors That Do Not Influence the Rating of the Aesthetic
Result The following factors did not exert any impact on
the patient satisfaction (p[ 0.05):
– Resection volume
– Type of oncoplastic technique
– Age at time of surgery
– Body mass index (BMI) at time of surgery
– Tumor localization
Glandular rotation mammaplasty            Dermoglandular rotation mammaplasty Tumor-adapted mastopexy
Lateral thoracic advancement flap Thoraco-epigastric flap Latissimus-dorsi flap   
FIG. 1 Surgical techniques
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n = 944 n = 624 n = 320
Characteristics No. % No. % No. %
Age group at time of surgery (year)
20–29 7 0.7 1 0.2 6 1.9
30–39 41 4.3 21 3.4 20 6.3
40–49 190 20.1 110 17.6 80 25.0
50–59 261 27.7 172 27.5 89 27.7
60–69 305 32.3 215 34.5 90 28.1
70–79 128 13.6 100 16.0 28 8.8
80–89 12 1.3 5 0.8 7 2.2
Unknown 0 0 0 0.0 0 0.0
BMI
Underweight (BMI 15–19.9 kg/m2) 56 5.9 27 4.3 29 9.0
Normal weight (BMI 20–24.9 kg/m2) 534 56.6 356 57.1 178 55.6
Overweight (BMI 25–29.9 kg/m2) 269 28.5 184 29.5 85 26.7
Obesity (BMI[ 30.0 kg/m2) 72 7.6 51 8.2 21 6.6
Unknown 13 1.4 6 0.9 7 2.1
Age of menarche (year)
\12 70 7.4 68 10.9
12–16 509 53.9 509 81.6
17–20 20 2.1 20 3.2
[20 2 0.2 2 0.3
Unknown 343 36.3 25 4.0
Age at menopause (year)
\30 3 0.3 3 0.5
30–39 32 3.4 32 5.2
40–49 239 25.3 239 38.3
50–59 206 21.8 206 33.0
C60 7 0.7 7 1.1
Unknown 457 48.4 137 21.9
Menopause status at time of surgery
Premenopausal 61 6.5 61 9.8 0 0.0
Perimenopausal 11 1.2 11 1.8 0 0.0
Postmenopausal 576 61.8 469 75.2 107 33.4
Unknown 296 31.3 83 13.2 213 66,6
Hormone replacement therapy
Administered, duration unknown 152 16.1 109 17.5 43 13.5
Administered up to 10 years 123 13.0 120 19.2 3 0.9
Administered 10 years or more 270 28.6 269 43.1 1 0.3
Not administered 121 12.9 114 18.3 7 2.2
Unknown 278 29.4 12 1.9 266 83.1
Family history of breast cancer
BRCA-positive 18 1.9 18 2.9 0 0.0
BRCA-negative 235 24.5 194 31.1 41 12.8
Negative 398 42.2 397 63.6 1 0.3
Unknown 2934 31.4 15 2.4 278 86.9
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The following boxplots illustrate the independence of
the aesthetic result from the factors: resection volume, type
of surgery, and localization of the tumor (Fig. 3a–c).
Patients across all ages and all BMI groups reported a
high degree of satisfaction with the aesthetic result. BMI
did not have any impact on the aesthetic result (p[ 0.05).
The majority of patients denoted that oncoplastic surgery
did not have an impact on partnership (88 %) or body
image (74 %).
Reexcision Rate and Necessity of Secondary
Mastectomy to Achieve Local Control
In 11.4 % (108/944) of patients, margins were unclear
after first oncoplastic surgery, of which 89.8 % (97/108)
underwent reexcision. This resulted in a margin clearance
of 96.9 % for all patients opting for reexcision. However
10.2 % (11/108) of patients did not undergo reexcision.
Finally, a proportion of 1.5 % (14/944) of the whole on-
coplastic cohort remained with unclear margins.
Factors that influenced the clearness of margins were
multicentricity or multifocality of tumors (p\ 0.001).
Neither T stage nor resection volume had an impact on
primarily achieved margin status (p[ 0.05).
In a total of 7.2 % (68/944) of the cohort, a secondary
mastectomy had to be performed. We identified ductal
carcinoma in situ (DCIS) (p = 0.001) with and without
invasive subtype as an independent risk factor for a sub-
sequent mastectomy, and likewise this was the case for
lobular histology (p = 0.001). A total of 13.6 % (n = 15/
110) of lobular histology underwent mastectomy, whereas
5.8 % (n = 33/572) of invasive ductal histological subtype
underwent this procedure.
Mastectomy as a subsequent procedure did not correlate
with the choice of oncoplastic technique used for primary
surgery (p[ 0.05).
In 77.4 % (n = 731/944) of patients, the first on-
coplastic operation was the definitive and final procedure.
In 22.6 % (213/944) of cases, patients underwent two more
surgical procedures. Reasons other than clearance of mar-
gins for a subsequent operation were bleeding in 5.0 % (47/
944), contralateral alignment in 1.9 % (18/944), and de-
hiscence of scars in 0.4 % (4/944).
Local Recurrence Rates
Thirty-eight women (4.0 %) experienced a local recur-
rence at a median follow-up time of 5.2 years. We detected
no significant difference between the oncoplastic tech-
niques. Five-year disease-free survival was 90.9 %, and
5-year overall survival was 94.5 %.
DISCUSSION
Optimal local tumor control and the prevention of re-
currence or metastatic spread by surgery, radiotherapy, and
systemic therapy are the primary goal of breast cancer
treatment.14 The systematization of oncoplastic operations
presented in our study facilitates a high degree of local
oncological control for any tumor localization and almost
any tumor size. Nomograms for oncoplastic surgery were
published by Veronesi et al., who presented reconstructive
variations after quadrantectomy with higher aesthetic out-
comes.15 The local recurrence rate in our study of 4.0 % is
low in the context of international literature, where recur-
rence rates up to 9 % are reported in similar cohorts.16,17 In
FIG. 2 Selection of oncoplastic techniques
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a recent meta-analysis of Losken et al., local recurrence
occurred in oncoplastic patients only at a rate of 4 %
compared with patients operated with breast-conserving
therapy (7 %).1 The rate of subsequent operations per-
formed in our cohort corresponds with international data, in
which reexcision rates from 10 to 18 % are described.18–20
The conversion rate from oncoplastic procedure to mas-
tectomy is low at 7.2 % in our cohort. This emphasizes the
fact that extensive autologous or heterologous reconstruc-
tions may be spared when appropriate oncoplastic
techniques are primarily applied.21 DCIS, multicentricity,
and multifocality are known factors for a higher rate of
local recurrence and consecutively mastectomy.14 Multi-
centric DCIS has been described as an indication for a
subsequent mastectomy.22
Clear margins go along with a reduced risk of local re-
currence whatever the distance of margins has been.23 In
international literature, rates of unclear margins from 10.6 to
38 % are described.24–28 Our results were comparably low
with a rate of 11.4 % of unclear margins after primary
surgery.
Only a few patients of our cohort refused reexcision of
unclear margins (n = 11). We did not detect any recurrences
in these patients during the period of 5-year follow-up.
There was no significant correlation between a certain
oncoplastic technique and the rate of unclear margins. In
2013, Down et al. demonstrated an advantage of oncological
safety (lower rate of unclear margins) through oncoplastic
techniques in a cohort of 158 patients. Oncoplastic techniques
have been applied whenever the estimated volume of resec-
tion was higher than 10 % of breast volume in the inner
quadrants and 20 % in the outer quadrants.29 Similar rec-
ommendations were given by Veronesi et al.30
Not only oncological safety but also aesthetic aspects
are centrally incorporated in the oncoplastic concept as
Cardoso and Heneghan et al. stated.31,32 Controversial data
are reported as to patient satisfaction with the aesthetic
result with a range of 40–89.5 %.1,33 We recorded a high
degree of patient satisfaction with the aesthetic result at the
upper range of internationally published data with 88 % of
patients being satisfied with the aesthetic result.
Over a wide range of 11–793 (median 32) g, breast
conservation appears feasible following this nomogram.
Breast-tumor ratio and relative excision volume goes along
with generally worse cosmetic outcome if conventional
breast-conserving therapies are applied.34–37 Yang et al.
demonstrated a high degree of satisfaction with aesthetic
results independent of the extent of excision volume by
using oncoplastic surgical techniques.7 Waljee et al. re-
ported as treatment-related factors predictive for
asymmetry: reexcision, postoperative seroma, and radio-
therapy.38 These factors were comparatively low in our
cohort. Tumor localizations in the upper inner and lower
outer quadrant impose a high challenge to the surgeon´s
skills with the risk of asymmetry.39 Even in difficult tumors
locations, we did not find a deterioration of patient satis-
faction; likewise, it was published in a smaller case series
by Fitoussi et al.40 Most recently, smaller studies with
oncoplastic techniques reported 72 patients that underlined
the necessity of contralateral alignment during the same
operation, which was performed in 53 of 72 patients
(73.6 %) published by Rose et al.20 We report a low rate of
1.9 % (18/944 patients) with contralateral alignment op-
eration. BMI and age did not have a negative impact on the
rating of the aesthetic outcome in our cohort contrary to
other study data.31,41
TABLE 2 Oncoplastic techniques by tumor location
Tumor location





n (%) n (%) n (%) n (%) n (%) n (%)
Glandular rotation mammaplasty 47 (36.2) 70 (63.1) 68 (68.0) 405 (69.5) 12 (60.0) 602 (63.8)
Dermoglandular rotation mammaplasty 8 (6.2) 2 (1.8) 3 (3.0) 49 (8.4) 1 (5.0) 63 (6.7)
Tumor-adapted mastopexy 72 (55.4) 33 (29.7) 23 (23.0) 66 (11.3) 3 (15.0) 197 (20.9)
Lateral thoracic advancement flap 2 (1.5) 1 (0.9) 3 (3.0) 36 (6.2) 0 (0.0) 42 (4.4)
Latissimus-dorsi flap 0 1 (0.9) 0 5 (0.9) 1 (5.0) 7 (0.7)
Others 1 (0.8) 2 (2.7) 3 (3.0) 19 (3.3) 1 (5.0) 27 (2.9)
Unknown 0 1 (0.9) 0 3 (0.5) 2 (10.0) 6 (0.6)
Total 130 (13.8) 111 (11.8) 100 (10.6) 583 (61.8) 20 (2.1) 944 (100)
a Lower inner quadrant, lower outer quadrant, 6 o’clock
b 3 and 9 o’clock
c Upper outer quadrant, upper inner quadrant, 12 o’clock
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CONCLUSIONS
The systematization of oncoplastic techniques in the
concept presented in this study (Fig. 3) embedded in a
multimodal concept of breast cancer therapy1–3 facilitates
tumor control with the use of uncomplicated techniques
adapted to tumor site and size with a median resection of
32 (range 11–793) g in this cohort. It demonstrated a high
level of satisfaction of patient-reported outcome using this
concept. These favourable results were independent from
age, BMI, resection volume, tumor localization, and type
of oncoplastic surgery. We identified postoperative pain as
an important factor to deteriorate patient satisfaction. This
underlines the need for a well-structured pain management
schedule postoperatively to eliminate this negative factor
that influences patient assessment of the surgical result.
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